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ABSTRACT 
Background 
Intracranial aneurysms may be difficult for endovascular treatment due to size, fusiform 
shape or wide neck. In such patients, intracranial stents are used to support the coils in the 
aneurysm sac, or they may be used as a sole stenting technique to divert the blood flow 
without coils. The aim of this paper is to contribute to the existing data by reviewing the 
risks of sole stenting of large and giant aneurysms.  
Methods  
We treated 7 patients with 9 aneurysms by self-expanding intracranial stents, either by a 
single or multiple stents in a stent-in-stent configuration. The follow-up was performed 
by digital subtraction angiography, with a mean follow-up time of 6 months. 
Results 
A positive response to stenting ocurred in 5 out of 7 patients (71%), and 6 out of 9 
aneurysms (67%). The aneurysms were occluded in 2 patients, and incomplete results 
were noted  in 3 patients. The symptoms due to the compression of cranial nerves 
resolved in 4 patients (57%). Procedure-related subarachnoid hemorrhage occurred in 2 
out of 7 patients (29%), with death of one patient as a result of hemorrhage (14%).  
Conclusions 
Sole stenting of large and giant aneurysms with self-expanding intracranial stents may be 
associated with a higher risk than previously reported. The effect of stenting on 
intraaneurysmal flow in such aneurysms, even after the placement of multiple 
overlapping stents, seems to be unpredictable.  
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INTRODUCTION 
Endovascular options in the treatment of intracranial aneurysms are expanding by the 
recent advances of materials and techniques. Aneurysms which are difficult for treatment 
due to wide neck, fusiform shape and incorporation of arterial branches are being treated 
by three-dimensional coils, balloon or stent-assisted coiling, parent artery occlusion, 
liquid embolics or combinations of these approaches [1,12,21,22,]. Various types of 
coronary and intracranial stents are used to support the coils in the aneurysm sac and/or 
to promote the thrombosis of the aneurysm and neointimal proliferation at the aneurysm 
neck by flow diversion. Stents may be used without coiling for the purpose of aneurysm 
thrombosis, in sole stenting technique, with favourable results [4,17,27,28,29,30,31,32], 
although serious complications have been described  [15]. New devices in forms of stents 
with a high-density wire mesh are being investigated and used in daily practice, with a 
potentially good compromise between flow diversion and preservation of perforating 
arterial branches [13,19]. However, the publications concerning sole stenting include a 
relatively small number of patients with limited follow-up time.  
We retrospectivelly analyzed our results on 7 patients with large and giant aneurysms 
treated by sole stenting with self-expanding intracranial stents. The aim of this paper was 
to contribute to the existing data and emphasise possible risks of this technique. 
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METHODS AND MATERIALS   
Indications for treatment were assessed for every patient by neuroradiologist performing 
endovascular treatment, vascular neurosurgeon and neurologist. The patients were 
referred to endovascular treatment due to the location of aneurysms on cavernous internal 
carotid artery (ICA) and basilar artery and their large and giant size, both of which factors 
are associated with higher surgical risks [9,25]. Extradural location of aneurysms and 
their wide neck or fusiform shape were considered suitable for sole stenting. All the 
patients were treated on a single-plane digital angiography system (Axiom Artis FA;  
Siemens AG, Erlangen, Germany), by self-expanding stents designed for intracranial 
vessels: Enterprise vascular reconstruction device (Codman Neurovascular, Warren, NJ), 
LEO Plus stent (Balt Extrusion, Montmorency, France) and Neuroform3 stent (Boston 
Scientific, Natick, MA). We aimed to use multiple closed-cell stents in a stent-in-stent 
configuration to achieve higher surface area coverage of the aneurysm neck. An open-cell 
Neuroform3 stent was placed in one patient, before the introduction of Enterprise and 
LEO stents in our practice. The choice between Enterprise and LEO stents was mostly 
influenced by their availability in our institution, as were the decisions to place a single 
stent in two patients. Pre-procedural dual antiplatelet medication consisted of 75 mg of 
clopidogrel daily and 100 mg of acetylsalicylic acid (ASA) daily during 3 days, or a 
loading dose of 300 mg of clopidogrel and 325 mg of ASA at least 4 hours before the 
procedure. The patients were heparinized during the procedure in order to double the 
baseline activated clotting time. The procedures were performed with patients in general 
anesthesia.  
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After the treatment, dual antiplatelet regimen was maintained for 6 weeks, and 100 mg of 
ASA daily was administered lifelong. 
The follow-up of patients with endovascularly treated aneurysms in our institution is 
routinely performed 3 months after the treatment by 3D time-of-flight magnetic 
resonance angiography, and 6-12 months after the treatment by digital subtraction 
angiography (DSA). In patients treated by sole stenting, however, the follow-up was 
performed by DSA to avoid misinterpretation due to magnetic resonance signal from 
expected thrombus in the aneurysm and artifacts caused by metallic stents. The follow-up 
examinations were performed after 3 months and in the period from 6-12 months after the 
treatment. 
This paper has been written in accordance with ethical standards laid down by the 
declaration of Helsinki and after the appropriate insitutional clearance. All the patients 
gave their informed consent for enrollment in this retrospective research. 
 
RESULTS 
Among 311 patients with intracranial aneurysms treated endovascularly in our institution 
from 2003 to 2009, 7 patients (6 female, 1 male) with large and giant aneurysms were 
treated by sole stenting. The mean age of the patients was 59 years, ranging from 43 to 
81. Three patients had giant aneurysms, over 25 mm in diameter, while 4 patients had 
large aneurysms, measuring 10-25 mm. The mean size of large and giant aneurysms was 
20 mm. One patient with a large cavernous ICA aneurysm had two additional small 
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aneurysms at C7 segment of the same artery, and stents covered the necks of all three 
aneurysms.  
Demographic data, characteristics of the aneurysms, type and number of implanted stents 
and results of the treatment are provided in Table 1. The Enterprise stent is manufactured 
only in a diameter of 4.5 mm, so Table 1 provides only the lengths of implanted stents. 
 
All the patients were symptomatic with ophtalmoplegia present in five patients, due to 
cranial nerve compression. One patient with a partially thrombosed basilar trunk 
aneurysm (Patient 3) presented with right-sided hemiparesis caused by brainstem 
ischemia. One patient had impaired conscioussness, paresis of tongue and palate and 
progressive tetraparesis due to brainstem compression by the giant basilar artery 
aneurysm. 
A total of 16 intracranial stents were deployed, the majority of which were closed-cell 
stents: 12 Enterprise stents and 3 LEO stents, while one stent was an open-cell 
Neuroform3 stent. 5 patients were treated by multiple stents, and 2 patients received a 
single stent. 
Immediate results 
There were no immediate complete angiographic exclusions of the aneurysms from 
circulation. Immediate partial result, seen angiographically as partial exclusion of the 
aneurysm from circulation or slower intraaneurysmal flow, occured in 5 patients, while in 
2 patients there were no immediate results.  
Follow-up 
Table 1 
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Angiographic follow-up ranged from 3 months to 1 year, with a mean follow-up time of 6 
months. At follow-up, the aneurysms were completely thrombosed in 2 patients and 
incomplete results were noted in 3 patients, for a total of 5 patients or 71%. This positive 
response to stenting occurred in 6 out of 9 aneurysms (56%): 5 large and giant  
aneurysms and 1 small aneurysm in a patient with multiple aneurysms. In one patient 
there was no change in aneurysm size and morphology after one year. Two patients with 
previously unruptured aneurysms suffered subarachnoid hemorrhage on the second and 
third day after the treatment, respectivelly. One of these patients died 3 days after the 
treatment and the death was considered procedure-related.  
The overall complication rate was 29% (2/7 patients), which included SAH in one patient 
and SAH and ischemia in the other patient. The procedure-related mortality was 14% (1/7 
patients).  
The symptoms due to the compression of surrounding structures, mainly cranial nerves, 
resolved in 4 patients (57%) with ICA aneurysms: in one patient with a complete 
occlusion of the aneurysm, in two patients with partial results and in one patient with no 
angiographic result. 
One patient with an immediate partial result had no further angiographic improvement 
after 6 months and was treated by additional coiling. One patient that had no 
angiographic result 1 year after sole stenting remained in follow-up without further 
treatment, since her symptoms due to extradural ICA aneurysm were gradually resolving. 
 
Illustrative cases 
 8
 
Patient 2 
A 51-year old man was hospitalized for a planned treatment of an unruptured giant 
basilar trunk aneurysm. Patient had altered consciousness with somnolence progressing 
to stupor during weeks before the treatment, paresis of tongue and palate and progressive 
tetraparesis due to brainstem compression by the giant basilar artery aneurysm. 
Angiography preceding the implantation of stent was performed by double injection of 
the contrast agent in both vertebral arteries to precisely evaluate the aneurysm, since there 
was no adequate visualization of basilar artery itself in previous examination. The 
aneurysm was arising at the level of anterior inferior cerebellar arteries, with slow and 
diminished distal flow, which was visible only after an injection through a microcatheter 
(Prowler select plus, 0,021, Codman Neurovascular, Warren, NJ) (Figure 2a,b). Three 
Enterprise stents (two stents 4,5 mm x 37 mm, one stent 4,5 mm x 28 mm) were 
implanted in a stent-in-stent configuration across the aneurysm neck with a marked 
reduction of flow in the aneurysm and improvement of distal flow (Figure 2c,d). The 
patient has been kept on dual antiplatelet regimen after the procedure, and experienced 
significant improvement of his clinical condition, untill on the third day after the 
treatment he lost conscioussness. Computed tomography (CT) scan revealed diffuse 
subarachnoid and intraventricular hemorrhage with brain edema, and the patient died.  
Retrograde analysis of angiographic images led to a conclusion that the site of rupture 
may have been at the distal part of the aneurysm, near the neck, probably due to the 
Figure 1 
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redistribution of blood inflow (Figure 2d). Contrast retention in the aneurysm may have 
been associated with reduced blood outflow. 
 
Patient 6 
A 54-year old female patient presented with left retroorbital pain and diplopia of the left 
eye. She had prominent palsy of the left abducens nerve. CT and CT angiography 
disclosed a large unruptured aneurysm of the C7 segment of the left ICA and she was 
referred to endovascular treatment. After dual antiplatelet preparation, the neck of the 
aneurysm was bridged by 4 closed-cell stents in a stent-in-stent configuration, with 
immediate slowing of the blood flow in the aneurysm with narrower inflow and improved 
distal flow (Figure 3a,b). There were no intraprocedural complications, and the patient 
was kept on dual antiplatelet medications. 24 hours after the procedure, she developed 
sudden right hemiparesis and lost conscioussness. CT scan revealed acute subarachnoid 
hemorrhage and an acute ischemia in the left anterior and middle cerebral artery territory 
(Figure 3c,d). At MR angiography there was no flow in the left terminal ICA, the 
aneurysm and left MCA. The patient gradually stabilized and was transferred to a 
rehabilitation centre.  
 
 
 
DISCUSSION 
Figure 2 
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Sole stenting was reported for the first time as an ancillary method to stent-assisted 
coiling [14,18], and is recently receiving attention as a planned definitive method of 
treatment of intracranial aneurysms. This method is appealing since modern intracranial 
stents are easily deployed, even in a stent-in-stent fashion, with low risk for vessel injury 
and short procedure times. Furthermore, thromboembolic events seem to be less frequent 
in patients who undergo stent-assisted coiling then in those treated by coiling alone, 
probably attributed to antiplatelet medications, accentuating the safety of stenting [6]. In 
comparison with coiling, which aims to fill the aneurysmal sac, stenting has the 
theoretical advantage of treating the diseased segment of the parent artery wall where the 
aneurysm arises. Published results are mostly in favor of this technique, although the rate 
of complications may reach up to 10% [8,17,32]. 
We retrospectivelly analyzed our results on 7 patients treated by stenting. These results 
are  poor, with complete occlusion of aneurysms in 2  patients at the mean follow-up time 
of 6 months, which may not be the sufficient follow-up time for the full effect of stent to 
occur [3]. 
Hemorrhagic complications 
Aneurysms in two patients ruptured within 3 days of the procedure and one patient died 
as a result of treatment. These results may be partially due to the fact that the patients had 
large and giant symptomatic aneurysms with wide neck or fusiform in shape, which are 
difficult for any type of treatment. Nevertheless, the rupture of 2 out of 7 treated large 
and giant aneurysms within days of the procedure represents a high bleeding rate of 29% 
which was unexpected, especially having in mind that these two aneurysms were treated 
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by 3 and 4 overlapping stents, respectively. This was expected to result in a higher 
surface area coverage of the orifice of the aneurysm, providing additional security against 
rupture. The pathogenesis of rupture of these aneurysms after treatment is not entirely 
clear. Both procedures were uneventful, with short procedure times and with standard 
pre- and postprocedural antiplatelet regimen, which is accepted by most authors. After 
the procedures, the patients were monitored in neurological intensive care units, with no 
adverse events noted. In these two patients, we speculate that the causes of rupture may 
have been a changed direction and narrowing of blood inflow, since the computational 
dynamics of in-vivo intraaneurysmal flow showed that ruptured aneurysms may have a 
changing region of impingement as well as narrower inflow jets, compared to unruptured 
ones [7]. The sizes of aneurysms in these two patients were 31 mm and 20 mm, 
respectively. Such size inevitably stretches the wall of the aneurysm, making it thin and 
inflexible. Therefore it is more vulnerable to rupture by the suddenly narrowed inflow jet 
of blood, which is directed to a different part of the aneurysm as a result of stents at the 
orifice of the aneurysm. In both patients, at final angiograms at the end of the procedure, 
the inflow jets were oriented slightly more distally at the upper portions of the 
aneurysms, compared to pre-treatment angiograms, supporting this hypothesis.  
The other factor which we should consider is the outflow from the aneurysm, which is 
most probably reduced as well, and may be seen angiographically as the retention of 
contrast in the aneurysm. Although it suggests slowing of the intraaneurysmal blood flow 
which promotes thrombosis, it may be dangerous if combined with persistent and 
narrower inflow jet. The subsequent rise of intraaneurysmal pressure may result in 
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rupture [32]. Although some authors report similar complications [15], the overall rate of 
SAH after sole stenting is low, up to 2.1 % [10,11,32]. These reports focused on the 
treatment of small aneurysms, in contrast to those in our patients, which may be the cause 
of significantly higher rate of post-treatment aneurysm rupture in our series.  
In patient 6, there were signs of bleeding as well as a large ischemic infarction. We 
speculate that the aneurysm ruptured and subsequently the formation of thrombus 
occluded both the aneurysm and the parent artery, causing ischemia.  
Antiplatelet medication and risk of hemorrhage 
Stenting is proposed to promote aneurysm thrombosis by redistribution of flow away 
from the aneurysm, by bridging of the diseased vessel wall at the aneurysm neck and by 
the change of arterial angle. At the same time, porosity of the stent preserves perforating 
arteries. The process of aneurysm thrombosis is, however, hampered by the necessity of 
antiplatelet medications, which may be an inherent problem of the technique. 
We excluded the patients who had previous subarachnoid hemorrhage due to the need of 
pre- and postprocedural antiplatelet therapy, although there is growing body of data  
indicating that the risk of rebleeding after stenting of acutely ruptured aneurysms is very 
low [11,20,24,26,32]. However, these studies varied regarding the timing and the type of 
antiplatelet medication, using intraprocedural abciximab and postprocedural ASA and 
clopidogrel therapy [11]; ticlopidine postprocedurally [20]; or intraprocedural tirofiban  
and ASA and clopidogrel after the treatment [32]. We avoid stenting in the setting of 
acute SAH whenever possible, since there are no clear guidelines regarding antiplatelet 
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therapy, and the number of reported patients treated by this method is still relatively 
small. 
Design and number of stents 
We treated all the patients with dedicated intracranial stents, mostly of a closed-cell type. 
These stents are, however, designed primarily for a purpose of stent-assisted coiling, not 
for the reconstrution of blood flow in the parent artery. Other devices, such as balloon-
expandable coronary stents, are more rigidly structured and may provide additional 
change of arterial angle with more accentuated flow redistribution [32]. Such stents also 
have up to three times higher surface area coverage than self-expanding stents. This may 
contribute to a higher degree of aneurysm occlusion [30,31]. On the other hand, both 
aneurysms that ruptured after stenting in our series were bridged by multiple stents, 
which probably provided a comparable or even higher surface area coverage and rigidity 
compared to balloon expanding stents. This density of mesh across the aneurysm neck 
may, however, only be assumed, since there is no possibility of actual visualization of 
overlapping stent struts during flouroscopy. 
It may be difficult to decide how many intracranial stents should be applied across the 
neck of the aneurysm to adequately redistribute the flow. Double-stenting method has 
been suggested as more efficient [5,16,24], and we aimed to place multiple stents in our 
patients. The drawback of such treatment is virtually impossible microcatheterization of 
the aneurysm in case of recanalization or regrowth.   
Our study is limited by a small number of patients and a heterogeneity regarding the type 
of stents we used. Longer follow-up of the patients may be necessary. 
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In conclusion, this limited series suggests that the results of sole stenting in the 
endovascular treatment of large and giant aneurysms may be unpredictable with the 
possibility of severe complications. The use of coronary stents in the management of 
small wide-necked aneurysms may bring more satisfying results. 
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Table 1. Summary of the results of patients treated by sole stenting 
 
Patients, 
sex, age 
Aneurysm characteristics 
Complication 
Stent type and 
size (mm) 
Immediate 
result 
Follow –up 
result 
Artery, 
segment 
Size Neck 
Clinical 
Presentation 
1, f , 75 y ICA, C4  26 mm  12 mm ophtalmoplegia none 
Enterprise 28 
Enterprise 22 
partial 
complete, 
1y 
2, m, 51 y  basilar trunk 31 mm 23 mm 
impaired 
consciousness, 
cranial nerve 
palsy 
3d SAH, 
death 
Enterprise 37 
Enterprise 28 
Enterprise 28 
partial death, 3d 
3, f, 48 y basilar trunk 10 mm 5 mm hemiparesis none 
Enterprise 22 
Enterprise 22 
partial 
partial,  
coiled 6m 
4, f, 81 y ICA, C4  15 mm fusiform ophtalmoplegia none 
Neuroform3  
4.5 x 30 
none none, 1y 
5, f, 63 y 
ICA, C4 
+ 2 small 
C7 
aneurysms  
14 mm,  
2 mm,  
3 mm 
7 mm,  
2 mm,  
3 mm 
ophtalmoplegia none 
Enterprise 37  
Enterprise 37 
LEO 3.5 x 25 
partial partial, 3m 
6, f, 54 y ICA, C7  20 mm 7 mm ophtalmoplegia 
2d SAH + 
ischemia 
Enterprise 22  
Enterprise 22  
Enterprise 14 
LEO 4.5 x 25 
partial 
complete 
PAO, 2d 
7, f, 43 y ICA, C4-C7  27 mm 10 mm ophtalmoplegia none LEO 4.5 x 40 
none partial, 3m 
 
m – male, f – female, ICA – internal carotid artery, SAH – subarachnoid hemorrhage, 
PAO – parent artery occlusion, y – year, m – month, d - day 
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FIGURE LEGENDS 
 
Figure 1 
2a,b: A giant basilar artery aneurysm shown by double vertebral artery injection with  
diminished distal flow, which is assessed by microcatheterization of basilar artery distal 
to the aneurysm. 2c: Unsubtracted image with contrast retention in the aneurysm after the 
placement of 3 stents; stents are depicted by arrows. 2d: Significant reduction of blood 
flow in the aneurysm with improvement of distal flow 
 24
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Figure 2 
3a: Digital angiography showing giant intradural ICA aneurysm. 3b: Slower filling of the 
aneurysm and improvement of distal arterial flow after the placement of 4 stents. 3c: 
axial CT image 24 hours after the treatment reveals subarachnoid hemorrhage. 3d: Loss 
of gray-white matter differentiation due to acute ischemia in the territory of left anterior 
and middle cerebral artery 
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